Philips Launches HealthSuite System of Engagement with New AI Capabilities to Accelerate the Digitalization of Healthcare

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the HealthSuite System of Engagement, an integrated, modular set of standards-based capabilities that support the development of digital health propositions, including new capabilities for cloud-based managed AI workflow and DICOM interoperability.

"While there are compelling examples of digitalization improving healthcare delivery, too often patients and care providers struggle within a complex, fragmented technology and data landscape that hampers the deployment of innovative healthcare services," said Jeroen Tas, Chief Innovation & Strategy Officer, member of the Executive Committee Royal Philips. "The HealthSuite System of Engagement is at the core of Philips' digital transformation. It’s a highly secured, modular set of capabilities that can liberate and integrate data from disparate systems and accelerate the development and deployment of digital propositions across the health continuum in a secure environment."

HealthSuite System of Engagement

In contrast to many ‘systems of record’, which are typically based on static, siloed files of patient information, the HealthSuite System of Engagement enables patients and all the staff they interact with to better manage the care experience and pathways. By taking a federated approach to data integration, HealthSuite System of Engagement supports healthcare providers in capturing the value of data from across their existing IT infrastructure, reducing complexity for healthcare professionals and opening new opportunities for care innovation.

HealthSuite System of Engagement provides capabilities for IoT (Internet of Things), Identity and Access Management and HIPAA-compliant Data Management. Deployment models include hosting and operating health applications in the cloud, edge and on-premise. HealthSuite enables clinical and operational data to be federated and shared across systems and solutions from Philips and third parties within the healthcare enterprise. HealthSuite leverages this longitudinally federated data in its intelligence, dynamic workflow and user experience capabilities to allow healthcare providers to unlock the power of data in their Electronic Medical Records (EMRs) and other systems of record in care pathways, connecting users seamlessly with data to provide actionable insights.

HealthSuite AI capabilities

New capabilities include cloud-based storage and standards-based interoperability for Digital Imaging and Communication in Medicine (DICOM) data, in addition to native FHIR support. The new HealthSuite De-Identification Services automate the removal of personal and sensitive information from structured data in order to enable patient privacy when data is made available for data science research. The HealthSuite Clinical Data Lake is a new scalable micro-service that acts as a centralized big data repository for high-volume clinical data collection studies and includes controls to curate and manage data in a manner that addresses regulatory requirements.

HealthSuite System of Engagement is powering a wide range of both Philips and 3rd party connected healthcare applications, including:

  • Philips' flagship Image-guided therapy platform Azurion, which allows clinicians to easily and confidently perform a wide range of routine and complex procedures, helping them to optimize interventional lab performance and provide superior care.
  • Philips Care Orchestrator for sleep and respiratory therapy, a smart cloud-based application that connects homecare providers, physicians, and payers with patients quickly and easily to critical data across devices and locations.
  • Philips Electronic Medical Records and Care Management (Tasy EMR), a comprehensive healthcare informatics solution that touches all areas of the healthcare environment, connecting the dots across clinical and non-clinical domains along the healthcare continuum.
  • The Philips remote patient monitoring program (eCareCoordinator and eCareCompanion), which provides care teams with tools to remotely track the health of their patients at home, collaborate with the patients' doctors and help detect problems before they lead to readmissions

For more information on Philips’ full portfolio of Philips secure, connected and intelligent informatics that will be spotlighted in Booth #2701 at the HIMSS Global Conference & Exhibition in Orlando, U.S., March 9-13, visit Philips HIMSS and follow @PhilipsLiveFrom for #HIMSS2020 updates throughout the event.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...